Production (Stage)
Oragenics, Inc.
OGEN
$4.28
$0.7521.25%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 341.50K | 1.67M | 879.00K | 906.80K | 663.40K |
| Gross Profit | -341.50K | -1.67M | -879.00K | -906.80K | -663.40K |
| SG&A Expenses | 1.68M | 1.69M | 1.56M | 1.40M | 1.80M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.03M | 3.36M | 2.44M | 2.31M | 2.46M |
| Operating Income | -2.03M | -3.36M | -2.44M | -2.31M | -2.46M |
| Income Before Tax | -2.22M | -3.35M | -2.46M | -2.31M | -2.45M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.22M | -3.35M | -2.46M | -2.31M | -2.45M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.22M | -3.35M | -2.46M | -2.31M | -2.45M |
| EBIT | -2.03M | -3.36M | -2.44M | -2.31M | -2.46M |
| EBITDA | -- | -3.35M | -2.43M | -2.30M | -2.45M |
| EPS Basic | -3.65 | -8.43 | -11.32 | -15.27 | -21.03 |
| Normalized Basic EPS | -2.28 | -5.27 | -7.07 | -9.54 | -13.15 |
| EPS Diluted | -3.65 | -8.43 | -11.32 | -15.27 | -21.03 |
| Normalized Diluted EPS | -2.28 | -5.27 | -7.07 | -9.54 | -13.15 |
| Average Basic Shares Outstanding | 607.10K | 397.20K | 217.60K | 151.00K | 116.50K |
| Average Diluted Shares Outstanding | 607.10K | 397.20K | 217.60K | 151.00K | 116.50K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |